Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v14-EN | Version v3-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2020-01-24 | 2019-08-16 |
| Drug Identification Number | 02241819 | 02241819 |
| Brand name | AVALIDE | AVALIDE |
| Common or Proper name | Avalide | Avalide |
| Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
| Ingredients | HYDROCHLOROTHIAZIDE IRBESARTAN | HYDROCHLOROTHIAZIDE IRBESARTAN |
| Strength(s) | 12.5MG 300MG | 12.5MG 300MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 90 | 90 |
| ATC code | C09DA | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2019-08-15 | |
| Actual start date | 2019-10-02 | |
| Estimated end date | Unknown | 2019-10-07 |
| Actual end date | 2020-01-23 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Increase in demand, supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. | Increase in demand, supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. |
| Health Canada comments |